About the show
A top podcast for healthcare leaders, with over one million downloads, Radio Advisory is your weekly download on how to untangle the industry's most pressing challenges to help leaders like you make the best business decisions for your organization.
From unpacking major trends in care delivery—like site-of-care shifts and the rise of high-cost drugs—to demystifying stakeholder dynamics, to shining a spotlight on priorities that may get overlooked, we're here to help. Our hosts and seasoned researchers talk with industry experts to equip you with knowledge to confront today's unanswered questions in healthcare. New episodes drop every Tuesday. | www.advisory.com
Episodes
-
211: Pursuing financial sustainability in cell and gene therapy delivery
June 4th, 2024 | 28 mins 41 secs
clinical innovation and affordability, provider strategy and financial outlook
The conversation around cell and gene therapies often centers on payers and purchasers, and the challenge of financing access to these expensive treatments. But there’s a key stakeholder missing from that discussion: the providers. In the final episode of our series on bespoke care and innovation, host Rachel Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to highlight the delivery side of the equation and unpack how providers are grappling with how to get these life-changing treatments to those that need them: patients.
-
210: How you approach precision medicine matters—for some patients more than others
May 28th, 2024 | 31 mins 43 secs
clinical innovation and affordability, health equity
In this episode, host Rachel Woods invites Advisory Board clinical innovation experts Amanda Okaka and Fanta Cherif to break down the health equity conundrum presented by precision medicine: Will precision medicine reduce disparities, or exacerbate them? The answer depends on the actions—big and small—of industry leaders.
-
209: Predicting what oncology will look like in 2030
May 21st, 2024 | 30 mins 43 secs
service lines
In this episode, host Rachel Woods invites Advisory Board specialty care experts Lindsey Paul and Julia Elder to discuss what the future of cancer care will look like and what changes the industry needs to make in order to prepare.
-
208: Authors Jim and Bob Rebitzer ask, "Why can't healthcare be better and cheaper?" (Live from The Players 2024 Championship)
May 14th, 2024 | 44 mins 25 secs
clinical innovation and affordability, external guests
Host Rachel Woods invites economist Jim Rebitzer and healthcare consultant Bob Rebitzer, to address the question of their recent book – why can't healthcare be better and cheaper?
-
207: Nurses Week 2024: Build care teams, not assembly lines
May 7th, 2024 | 30 mins 40 secs
clinical workforce
Host Rachel Woods sits down with Advisory Board nursing experts Monica Westhead, Allyson Paiewonsky, and Ali Knight to discuss nursing workforce challenges and the barriers getting in the way of meaningful, sustainable solutions.
-
206: 24th Secretary of HHS Alex Azar shares his vision on healthcare transformation
April 30th, 2024 | 57 mins 59 secs
external guests, leadership, value-based care
Host Rachel Woods sits down with the 24th Secretary of the U.S. Department of Health and Human Services Alex Azar to discuss how he defines industry transformation and what leaders can do to advance towards that vision.
-
205: Live from ViVE 2024: Four leaders on how technology is redefining clinical work
April 23rd, 2024 | 46 mins 22 secs
clinical workforce, external guests, tech and ai
In this episode, recorded live at ViVE 2024, host Rachel (Rae) Woods invites Dr. Nele Jessel, Chief Medical Officer at athenahealth, Dr. Jesse Ehrenfeld, President of the American Medical Association, Dr. Syl Trepanier, SVP and System Chief Nursing Officer at Providence, and Dr. Tina Shah, Chief Clinical Officer at Abridge, to discuss the ongoing workforce crisis, rising burnout, and how new technologies can help build a more sustainable workforce.
-
204: Unveiling "Bespoke Care": Healthcare's tailored future
April 16th, 2024 | 27 mins 31 secs
clinical innovation and affordability
The conventional wisdom of care delivery is changing. In this episode, host Abby Burns invites Advisory Board innovation experts Solomon Banjo and Nick Hula to unpack how unprecedented advancements in our ability to customize patient care is upending how we think about care delivery and financing. We've entered the era of "bespoke care."
-
203: Value series: Is the future of VBC in specialty care? Zing Health & Strive Health say yes.
April 9th, 2024 | 32 mins 27 secs
external guests, industry consolidation, service lines, value-based care
In the final episode of our value series, host Rachel Woods invites TJ Ackerman, Senior Vice President of Provider and Network Performance at Zing Health, and later Will Stokes, Chief Strategy Officer at Strive Health, to discuss what good specialty care looks like and why value-based specialty care is the future.
-
202: Value series: Why CenterWell (and Humana) is going all in on senior care
April 2nd, 2024 | 32 mins 12 secs
external guests, industry consolidation, value-based care
In part two of our value series, host Rachel Woods invites Dr. Sanjay Shetty, President of CenterWell, Humana's provider arm, to discuss how they are growing an effective value-based care strategy by focusing on senior care management.
-
201: Value series: What does health system VBC adoption actually look like?
March 26th, 2024 | 26 mins 31 secs
provider strategy and financial outlook, value-based care
To kick off our value series, host Abby Burns invites Advisory Board value-based care experts Clare Wirth and Daniel Kuzmanovich to shed light on how far health systems have actually progressed on the path to value-based care and break down why that journey – and its destination – will look different for every system.
-
200: Why 2024 is a make-or-break year for corporate medical groups
March 19th, 2024 | 32 mins 40 secs
industry consolidation, physician landscape
In this episode, host Rae Woods invites Advisory Board physician experts Sarah Roller and Eliza Dailey to discuss why 2024 will be a make-or-break year for corporate medical groups, and what that means for the rest of the industry.